Methods for the treatment of cognitive disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514299, A61K 3144

Patent

active

052449092

ABSTRACT:
The invention relates to the use of certain compounds which act as antagonists of 5-hydroxytryptamine (5-HT) at 5-HT.sub.3 receptors for the treatment of cognitive disorders such as attentional and memory deficits and dementia states.

REFERENCES:
patent: 4624961 (1986-11-01), Welstead, Jr.
patent: 4721720 (1988-01-01), Wootton et al.
patent: 4789673 (1988-12-01), Donatsch et al.
patent: 4803199 (1989-02-01), Donatsch et al.
patent: 4851407 (1989-07-01), Wooton et al.
Altman et al., Psychopharmacology, 90, 24-27 (1986).
Essman, Advances in Biochemical Psychopharmacology, 11, 265-274 (1974).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for the treatment of cognitive disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the treatment of cognitive disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of cognitive disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2026799

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.